Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amaryl and NovoRapid vs NovoMix 30 vs Lantus in Type 2 Diabetes
NCT00151697Phase 3Completed
- Sponsor
- Rijnstate
- Start
- May 2005
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of glimepiride, insulin aspart in type 2 diabetes mellitus (T2DM), sponsored by Rijnstate. Started May 2005; status: completed.
02
Drugs
glimepirideinsulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00151697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00151697.